[fusion_builder_container admin_label="" hundred_percent="no" equal_height_columns="no" menu_anchor="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="https://www.ologybio.com/wp-content/uploads/2017/09/377.jpg" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="fixed" enable_mobile="no" parallax_speed="0.3" video_mp4="" video_webm="" video_ogv="" video_url="" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" video_preview_image="" border_size="" border_color="" border_style="solid" margin_top="" margin_bottom="" padding_top="150px" padding_right="" padding_bottom="90px" padding_left=""][fusion_builder_row][fusion_builder_column type="1_1" layout="2_3" spacing="" center_content="no" hover_type="none" link="" min_height="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="#ffffff" background_image="" background_position="left top" undefined="" background_repeat="no-repeat" border_size="0" border_color="" border_style="solid" border_position="all" padding_top="50px" padding_right="50px" padding_bottom="30px" padding_left="50px" margin_top="" margin_bottom="" animation_type="" animation_direction="left" animation_speed="0.3" animation_offset="" last="no"][fusion_separator style_type="none" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" sep_color="" top_margin="40px" bottom_margin="" border_size="0" icon="" icon_circle="" icon_circle_color="" width="" alignment="center" /][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id=""] Privacy Policy [/fusion_text][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id=""] Website Privacy Policy Ology Bioservices, Inc. Revised as of 21 st June 2019 By visiting our website, you are accepting the practices described in this Privacy Policy We have created this privacy policy to demonstrate our firm commitment to the privacy of our visitors and customers. We are committed to respecting your privacy and recognizing your need for appropriate protection and management of personally identifiable information you share with us (the phrases "personally identifiable information" and "personal information" mean any information by which you, individually can be identified, such as your name, address, telephone number, etc.). The purpose of this privacy policy is to inform you when you visit our Website how we use such information, and the choices you have regarding our use of, and your ability to review and correct, your information. Personal Information Personal Identifiable Information or Personal Information mean any information by which you, individually can be identified, such as your name, email address, address, telephone number, financial information, etc. A Special Notice About Children Children (under the age of 18) are not eligible to use the Website unsupervised, and we ask that children do not submit any personal information to us. If you are under the age of 18, you may only use this Website in conjunction with, and under the supervision of, your parents or guardians. General In general, you may visit many pages of the Website without telling us who you are or revealing any personal information about yourself. We may track the Internet domain address from which people visit the Website and analyze this data for trends and statistics, but individual users will remain anonymous unless they voluntarily tell us who they are. Sometimes (such as when you purchase or order a product, subscribe to a service, register to receive catalogs, or participate in contests, sweepstakes, or promotions) we will ask you to provide personal information about yourself, such as your name, shipping/billing addresses, telephone number, e-mail address, credit card information, birth date, gender, occupation, or personal interests. We also maintain a record of your online purchases. Whether or not you choose to provide the information we request is entirely up to you. But if you choose not to provide the information we request, you may be unable to purchase products, or access certain services, offers, and content on the Website. Collection and Use of Personal Information If you choose to provide information to us through our online registration, you may be asked to provide us with personal information, including your name, address, postal address and telephone number, your e-mail address, a password, and other identifying information (such as your mother's maiden name, city of birth, or pet name). If you choose to purchase a product from us, we will collect additional personal information, including your billing address, shipping address, and credit card number and expiration date in order to process your purchase properly. We also may ask you for personal information when you ask us for information, subscribe to a Company service or publication, or download information. Your personal information enables us to provide you with the information you have requested, provide you with information regarding the status of your assets and transactions, fulfill your purchases, and provide you with information regarding future products and services that may suit your particular interests. We also use your personal information to help identify you if you lose your password and to help you quickly find information on the Website. If you believe that any of your personal information is incorrect, or has been changed since your registration at the Website, please send an e-mail message to info@ologybio.com explaining the correction or change and provide any relevant confirmation or reference number. Safe Harbor Company adheres to the U.S. safe harbor policy privacy principles of notice, choice, onward transfer, security, data integrity, access, and enforcement, and is registered with the U.S. Department of Commerce's safe harbor program [www.export.gov/safeharbor]. If you have any questions regarding this policy, contact Company through the Website or write to us at info@ologybio.com .. Cookies The Website uses cookie technology to improve the quality of your experience. A cookie is a small file that contains information sent by a website that is saved on your hard disk by your computer's browser. Cookies store information that a website may need in order to personalize your experience and gather website statistical data. Any time you visit the Website to browse or to read or download information, we collect and store the name of the domain and host from which you access the Internet (for example, msn.com, aol.com, etc.); the Internet protocol (IP) address of the computer you are using; the browser software you use and your operating system; the date and time you access the Website; and the Internet address of the website from which you linked directly to the Website. We use this information to measure the number of visitors to areas of the Website, and to help us make the Website more useful and interesting to our visitors. We use information from cookies in the aggregate to analyze for trends and statistics, and then discard it—we do not track individuals, only instances of entry onto the Website. You can control or reset your cookies through your web browser, which will allow you to customize your cookie preferences and to refuse all cookies or to indicate when a cookie is being sent. However, some features of the website may not function properly if the ability to accept cookies is disabled. Changes to the Privacy Policy We may update this Privacy Policy from time to time. If we make any material changes we will provide notice on this website, and we may notify you by email (sent to the email address specified in your account), prior to the change becoming effective. We encourage you to periodically review this page for the latest information on our privacy practices. If you continue to use the website after those changes are in effect, you agree to the revised policy. If you have any question about this Privacy Policy, please contact info@ologybio.com . Analytical data We may directly collect analytics data, or use third-party analytics tools, to help us measure traffic and usage trends for the Website. These tools collect information sent by your browser or mobile device, including the pages you visit and other information that assists us in improving your experience using our website. We collect and use this analytics information in aggregate form such that it cannot be reasonably be manipulated to identify any particular individual user. Your Rights You may have rights under applicable law to request and receive information about our disclosure of your personal information to unaffiliated third parties for direct marketing purposes. Under applicable law you may also request to your Personal Information blocked or deleted. To exercise your rights please contact us at info@ologybio.com . Specific to California Residents Your California Privacy Rights. We collect information that you provide to us or that we learn about you from your use of our websites as described in this Privacy Policy. Under California Law, once a year, Ology Bioservices customers who are California residents may request certain information about our disclosure of your personal information to unaffiliated third parties for direct marketing purposes. Ology Bioservices does not disclose any personal information to unaffiliated third parties for these purposes. Your California Privacy Rights. We collect information that you provide to us or that we learn about you from your use of our websites as described in this Privacy Policy. Under California Law, once a year, Ology Bioservices customers who are California residents may request certain information about our disclosure of your personal information to unaffiliated third parties for direct marketing purposes. Ology Bioservices does not disclose any personal information to unaffiliated third parties for these purposes. [/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

[fusion_builder_container admin_label="" hundred_percent="no" equal_height_columns="no" menu_anchor="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="https://www.ologybio.com/wp-content/uploads/2017/09/377.jpg" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="fixed" enable_mobile="no" parallax_speed="0.3" video_mp4="" video_webm="" video_ogv="" video_url="" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" video_preview_image="" border_size="" border_color="" border_style="solid" margin_top="" margin_bottom="" padding_top="150px" padding_right="" padding_bottom="90px" padding_left=""][fusion_builder_row][fusion_builder_column type="1_1" layout="2_3" spacing="" center_content="no" hover_type="none" link="" min_height="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="#ffffff" background_image="" background_position="left top" undefined="" background_repeat="no-repeat" border_size="0" border_color="" border_style="solid" border_position="all" padding_top="50px" padding_right="50px" padding_bottom="30px" padding_left="50px" margin_top="" margin_bottom="" animation_type="" animation_direction="left" animation_speed="0.3" animation_offset="" last="no"][fusion_separator style_type="none" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" sep_color="" top_margin="40px" bottom_margin="" border_size="0" icon="" icon_circle="" icon_circle_color="" width="" alignment="center" /][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id=""] Cookie Policy [/fusion_text][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id=""] Cookie policy with link to Privacy policy Ology Bioservices uses cookies to analyze website traffic to improve website functionality and provide you with a better browsing experience. Information about the use of cookies on this site and how you can decline them is provided in our privacy policy . By using this site or clicking Accept you consent to the use of cookies. [/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

[fusion_builder_container admin_label="" hundred_percent="no" equal_height_columns="no" menu_anchor="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="https://www.ologybio.com/wp-content/uploads/2017/09/377.jpg" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="fixed" enable_mobile="no" parallax_speed="0.3" video_mp4="" video_webm="" video_ogv="" video_url="" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" video_preview_image="" border_size="" border_color="" border_style="solid" margin_top="" margin_bottom="" padding_top="150px" padding_right="" padding_bottom="90px" padding_left=""][fusion_builder_row][fusion_builder_column type="1_1" layout="2_3" spacing="" center_content="no" hover_type="none" link="" min_height="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="#ffffff" background_image="" background_position="left top" undefined="" background_repeat="no-repeat" border_size="0" border_color="" border_style="solid" border_position="all" padding_top="50px" padding_right="50px" padding_bottom="30px" padding_left="50px" margin_top="" margin_bottom="" animation_type="" animation_direction="left" animation_speed="0.3" animation_offset="" last="no"][fusion_separator style_type="none" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" sep_color="" top_margin="40px" bottom_margin="" border_size="0" icon="" icon_circle="" icon_circle_color="" width="" alignment="center" /][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id=""] A Retrospective Introduction [/fusion_text][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id=""] Ology Bioservices is a trusted biopharmaceutical partner, providing high quality products and services for over 15 years, on-time and on-budget. Ology Bioservices, Inc. (Ology Bio) is a privately owned, US-based, mid-sized, Commercial Development and Manufacturing Organization (CDMO) providing services from sequence to Phase II, to both government and commercial clients. Ology Bio is headquartered in Alachua, FL at its best-in-class biopharmaceutical manufacturing facility, with additional sites in Berkeley, CA and Frederick, MD. Ology Bio is approved to produce drug substance to US, WHO and EU companies. Rebranding Ology Bio started out as a small biotech company called Nanocoat Technologies (2000), a product of the Sid Martin Biotechnology Incubator of Alachua, Florida , with expertise in nanometer-scale particle technology designed for use in the development of new drugs and medical devices (i.e. NanoGent,NanoDTPA™, NanoDOX®,NanoDRY®, and NanoFUSE ® DBM) and for increasing the efficacy of existing oral, parenteral and topical drugs. In2002, Nanocoat Technologies rebranded to Nanotherapeutics, Inc. and continued developing business through corporate alliances and government contracts. In 2013, Nanotherapeutics was awarded a DoD-funded defense contract to build an Advanced Development and Manufacturing (ADM) facility, which will ensure capacity in the event of a bioterrorism or radiological biothreat in the US. During construction of the 183,000 square foot, BSL-3 ready facility in Alachua, FL, Nanotherapeutics negotiated novation of XOMA Corporation’s biodefense program including on-going programs, associated materials and drug substance productions. In 2016, Nanotherapeutics rebranded to Ology Bioservices, Inc. (Ology Bio) when the corporate business plan changed to include commercial services in conjunction with government contracts funneled through the ADM facility. Bioterrorism, Outbreaks and Plague Ology Bio has a history as a “disruptor” in the medical countermeasure efforts by the US Government, as it has consistently moved government-funded programs forward at faster than expected rates with a series of significant successes. These events began with the 2005 US government program called ‘ Project Bioshield ‘(passed into law on July 21, 2004) funded to support the development of biotechnical and biopharmaceutical products and medical devices for use as medical countermeasure(s) (MCM) against “category A” agents capable of weaponization in acts of bioterrorism against the US. Ology Bio was 1 of 10 recipients of the program grants with specific focus on development of a delivery system for treatment against Pneumonic plague and tularemia. Category A agents are those biothreats posing the highest risk to public health and national security. These agents when properly delivered can be transmitted readily through a population resulting in high death counts and public panic. These agents are therefore the highest priority biothreats capable of causing great damage and include: Anthrax (Bacillus anthracis) – 2001 “Amerithrax” attack against US government Botulism (Clostridium botulinum toxin) – 1990’s attack of US military installations in Japan Plague (Yersinia pestis) – 1945 Japanese ‘Operation Cherry Blossom at Night’ Smallpox (variola major) – 1970-80’s Soviet stockpile Tularemia (Francisella tularensis) Viral hemorrhagic fevers with two sub-categories: Filoviruses (Ebola, Marburg) Arenaviruses (Lassa, Machupo) Ology Bioservices has partnered with several government departments and agencies to develop MCMs for biological agents released as biothreats or naturally-occurring. These partnerships have targeted tularemia, radiation poisoning, Human Immunodeficiency Virus, small pox, H5N1 influenza, Ebola virus, Ross River virus, Chikungunya disease, West Nile virus, botulinum neurotoxin, malaria and plague. Timeline Below is an abbreviated timeline of Ology Bio’s government-funded awards, proprietary products and strategic alliances. 2005 a –DoD contract for NanoGent delivering prophylaxis and treatment against pneumonic plague and tularemia. 2005 b – NIAID award to XOMA for mAb-based DP against BoNT/A, acquired by Ology Bio in 2016. 2005 c – NIAID award for NanoDTPA™ capsule to remove radioactive compounds from patients. IND filed in 2010 . 2011, FDA declared NanoDTPA™ capsule an orphan drug product. 2011 BARDA awarded funding for further development of DTPA for americium, curium, or plutonium exposures. 2006 – SBIR with RF Monolithics Inc. for a patented detection method to find improvised explosive devices (IEDs). 2007 a - CRADA with National Cancer Institute (Vaccines) for proprietary nanoparticle delivery system of an HIV-peptide vaccine. 2007 b – BARDA/NIAID (Pandemic and All Hazards Preparedness Act) award for antibiotics against pneumonic plague and tularemia. 2008 - IND submission for NanoDOX® Hydrogel, a proprietary doxycycline product for the topical treatment of chronic wounds. 2010 DoD (2009 - Accelerating Treatment for Trauma Wounds) contract for NanoDOX® Hydrogel use in a clinical trial. 2009 a – IND submission for NanoBUP TM , an opiate addiction treatment using the proprietary NanoDRY® particle delivery system. 2009 b - NIAID/NIH award development of an aerosolized antiviral treatment for smallpox (Variola major) using cidofovir. 2009 c - Acquired GelSite® biopolymer and GelVac TM nasal powder platform technology from DelSite (Carrington Laboratories, Inc.). 2010-2011 Successful Phase 1 clinical trial for GelVac H5N1 Flu vaccine . 2009 d –NIAID (Soligenix, Inc.) consortium for platform production of thermally stable vaccines to counter high-priority biothreats. 2013 – DoD contract for an Advanced Development and Manufacturing (ADM) facility. Note: designed to produce medical countermeasures against chemical, biological, radiological, and nuclear attacks and outbreaks of naturally occurring emerging and genetically engineered infectious diseases. 2013 b – BARDA award for influenza vaccine under Fill-Finish Manufacturing Network (FFMN) Pilot Production. 2014 a –Strategic alliance with PharmAthene to advance development of specific MCMs for the U.S. biodefense market. 2014 b - BARDA award for fill/finish of Zmapp, an antibody-based treatment of Ebola by Mapp Pharmaceuticals. 2015 a – BARDA/HHS two awards under FFMN for manufacture, process validation and FDA filing of select MCMs. 2015 b – Baxter divested Vero Cell vaccines platform and associated assets including: H5N1, H1N1, seasonal influenza vaccines Ross River virus, Chikungunya disease and West Nile virus vaccine programs. Partnered with Takeda to expand Vero Cell technology produced influenza vaccine availability to Japanese markets. 2015 c –Novated XOMA Corporation’s Biodefense program for anti-BoNT A, B, C/D and E drug products. 2016 -Licensed NanoFUSE ® DBM (demineralized bone matrix-bone void filler) to Amend Surgical, Inc. 2017 a –Licensed Triapine® (3-AP) a ribonucleotide reductase (RNR) inhibitor in nucleotide biosynthesis to Trethera Corporation. 2017 b –Alliance with Battelle to facilitate expedited research and development of MCMs for deployed military forces. 2017 c – Rebranded Nanotherapeutics to Ology Bioservices, Inc. 2018 a –Global Health Initiative Fund award to develop a vaccine candidate for treatment of Malaria. 2018 b – DoD/Defense Advanced Research Projects Agency (DARPA), for manufacture of the mAb114 antibody against Ebola. 2019 a – DoD award for development of a platform technology using monoclonal antibodies as MCMs against biothreats 2019 b – DoD award for platform use to develop a prophylactic drug product against the Plague bacterium, Yersinia pestis. Continuity and Commercial expansion The ADM facility is owned by Ology Bioservices and operates under government-oversight to ensure continuity of all government issued task orders and contracts for MCM development now and in the future. Extensive capacity was built into the ADM facility, which is available for use in Commercial business. The ADM facility is ISO 9001 and 13485 certified, for GMP manufacture. Ology Bio has continually expanded its capabilities in keeping with the needs of government and commercial clients, offering an equally expanding list of commercial services. Ology Bio’s Commercial Services (in alphabetical order) include: Bioanalytical development and testing Cell banking Drug substance production (GMP to 2000L) Molecular/vector development Plasmid production Process development and scale up (Non-GMP to 200L) Project management Regulatory support Small batch fill/finish Vaccine production Viral banking Ology Bio is expanding its capacity to provide services in support of Gene and Cell Therapy therapeutic development. Ology Bio will soon be opening a small batch manufacturing facility, with 2 upstream manufacturing suites, in Alameda, CA. [/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

Admin, Author at Ology Bioservices Global CDMO

Q: Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model

[fusion_builder_container hundred_percent="no" equal_height_columns="no" menu_anchor="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_mp4="" video_webm="" video_ogv="" video_url="" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" overlay_color="" video_preview_image="" border_size="" border_color="" border_style="solid" padding_top="" padding_bottom="" padding_left="" padding_right=""][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" background_position="left top" background_color="" border_size="" border_color="" border_style="solid" border_position="all" spacing="yes" background_image="" background_repeat="no-repeat" padding_top="" padding_right="" padding_bottom="" padding_left="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="no" min_height="" hover_type="none" link=""][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id=""] Tomic MT, Espinoza Y, Martinez Z, et al. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model . Toxins 2019, 11 (4), 208; https://doi.org/10.3390/toxins11040208 . Read More > [/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

About Admin

This author has not yet filled in any details.
So far Admin has created 88 blog entries.

Government Contracts for Biodefense

Government Contracts for Biodefense

Admin2020-02-10T11:58:46-05:00February 10th, 2020|

Government Contracts For Biodefense: The Benefits and Risks. Robert V. House, PhD, FATS, Senior Vice President of Government Contracts at Ology Bioservices shares his thoughts on the benefits of Government Contracting in an article recently published in the Washington Business Journal. Read it here

CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate

Admin2019-08-14T13:54:13-04:00August 14th, 2019|

CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate Public Health Vaccine, LLC. will partner with Crozet Biopharma to develop the Nipah vaccine candidateUp to $9 million of this funding will go to Ology Bioservices, Inc., to support manufacturing and stockpiling of [...]

Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc.

Admin2019-08-12T16:26:55-04:00August 12th, 2019|

Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc. PRESS RELEASE UPDATED: AUG 7, 2019 CINCINNATI, August 7, 2019 (Newswire.com) - Blue Water Vaccines, a Cincinnati-based biotechnology startup, has signed an agreement with Ology Bioservices, Inc. to manufacture a novel universal influenza vaccine. The vaccine, based on technology [...]

Blog Privacy Policy

Admin2019-07-12T14:56:33-04:00July 12th, 2019|

Privacy Policy Website Privacy Policy Ology Bioservices, Inc. Revised as of 21stJune 2019 By visiting our website, you are accepting the practices described in this Privacy Policy We have created this privacy policy to demonstrate our firm commitment to the privacy of our visitors and customers. We are committed to respecting [...]

Disclaimer/disclosure

Admin2019-07-12T14:59:43-04:00May 16th, 2019|

Disclaimer/Disclosure Ology Bio does not warrant that the information contained in this Website or Blog is accurate, complete, current, or useful. The information in this Website and Blog is provided without any express or implied warranties, including but not limited to warranties of merchantability, fitness for a particular purpose or noninfringement. The [...]

Cookie Policy

Admin2019-07-12T15:04:47-04:00May 16th, 2019|

Cookie Policy Cookie policy with link to Privacy policy Ology Bioservices uses cookies to analyze website traffic to improve website functionality and provide you with a better browsing experience. Information about the use of cookies on this site and how you can decline them is provided in our privacy policy. By using [...]

OlogyBio USG

Admin2019-07-12T14:46:07-04:00May 16th, 2019|

A Retrospective Introduction Ology Bioservices is a trusted biopharmaceutical partner, providing high quality products and services for over 15 years, on-time and on-budget. Ology Bioservices, Inc. (Ology Bio) is a privately owned, US-based, mid-sized, Commercial Development and Manufacturing Organization (CDMO) providing services from sequence to Phase II, to both government and commercial [...]

Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model

Admin2019-04-16T23:26:06-04:00April 16th, 2019|

Tomic MT, Espinoza Y, Martinez Z, et al. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Toxins 2019, 11(4), 208; https://doi.org/10.3390/toxins11040208. Read More >

Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million

Admin2019-04-15T11:00:59-04:00April 15th, 2019|

Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two [...]

Ology Bioservices Appoints Vaccines and Biologics Manufacturing Industry Veteran, Brandon Brega, as Chief Operating Officer

Admin2019-01-24T11:52:03-05:00January 24th, 2019|

Ology Bioservices Appoints Vaccines and Biologics Manufacturing Industry Veteran, Brandon Brega, as Chief Operating Officer ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today the appointment of vaccines and biologics manufacturing industry expert, Brandon Brega, to the position of Chief Operating Officer, effective immediately. In this [...]

12 Next